Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun;22 Suppl 4(Suppl 4):549-55.
doi: 10.1007/s00586-012-2339-3. Epub 2012 May 8.

Epidemiology of tuberculosis in WHO European Region and public health response

Masoud Dara  1 , Andrei Dadu, Kristin Kremer, Richard Zaleskis, Hans H P Kluge
Affiliations
Review

Epidemiology of tuberculosis in WHO European Region and public health response

Masoud Dara et al. Eur Spine J. 2013 Jun.

Abstract

Purpose: To provide an overview of the tuberculosis (TB) and multi-drug resistant tuberculosis (MDR-TB) in the WHO European Region and evolution of public health response with focus on extra-pulmonary tuberculosis and Pott's disease.

Methods: Authors reviewed regional strategic documents related to TB. The epidemiologic data were reviewed and analyzed.

Results: In the absence of associated pulmonary TB, Pott's disease is reported as extra-pulmonary TB (up to 47 % of all TB cases in some settings). Due to limitations of the surveillance system, the epidemiology of Pott's disease and its treatment success are unknown. The Stop TB Strategy and Consolidated Action Plan to Prevent and Combat M/XDR-TB provide comprehensive roadmaps to address all types of TB.

Conclusions: There is a need to further analyze country data to document the extent of Pott's disease and develop specific guidelines for timely diagnosis and treatment of Pott's disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Notification rate of new and previously treated TB patients per 100,000 population, in the WHO European Region in 2010 [1]
Fig. 2
Fig. 2
Treatment outcome among new laboratory-confirmed pulmonary TB cases, previously treated cases and MDR-TB cases in the WHO European Region in 2009
Fig. 3
Fig. 3
Percentage of extra-pulmonary tuberculosis reported in the WHO European Region in 2010
Fig. 4
Fig. 4
Expected achievements from implementation of the Consolidated Action Plan to present and combat M/XDR-TB in the WHO European Region, 2011–2015 [21]
See this image and copyright information in PMC

References

    1. European Centre for Disease Prevention and Control/WHO Regional Office for Europe . Tuberculosis surveillance and monitoring in Europe, report 2012. Stockholm: European Centre for Disease Prevention and Control; 2012.
    1. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, Thuong NT, Stepniewska K, Huyen MN, Bang ND, Loc TH, Gagneux S, van Soolingen D, Kremer K, van der Sande M, Small P, Anh PT, Chinh NT, Quy HT, Duyen NT, Tho DQ, Hieu NT, Torok E, Hien TT, Dung NH, Nhu NT, Duy PM, van Vinh Chau N, Farrar J. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008;4(3):e1000034. doi: 10.1371/journal.ppat.1000034. - DOI - PMC - PubMed
    1. World Health Organization WHO (1991) 44th World Health Assembly: resolutions and decisions–resolution WHA 44.8 (WHA44/1991/REC/1). Geneva
    1. The World Bank . World Development Report 1993: investing in health. New York: Oxford University Press; 1993.
    1. World Health Organization (1994). Global Tuberculosis Programme. Framework for effective tuberculosis control. Geneva, Switzerland, WHO/TB/94.179

MeSH terms

Substances